R&D Data Science
At Janssen Research & Development, we are reimagining the Discovery and Development of medicines using Data Science to advance our Mission of bringing transformative therapies to patients around the globe.
Join OUR Team
We are building a diverse team of bilingual data scientists and data engineers, fluent in medicine and Data Science, to bring heart and innovation to our mission and patients. Our data scientists are deeply embedded within the portfolio of projects focused on building transformational medicines for patients, working in full partnership with talented biologists, chemists, physicians, technologists and other key contributors across our global enterprise. Our commitment to diversity, equity and inclusion is visible in the Data Science team we have built. Whether you are just starting your career or are a seasoned professional, we welcome you to a dynamic atmosphere where the needs of patients are ever-present and where your next insight can help ignite our next breakthrough.
At Janssen, we pursue highly impactful problems that help us deliver better medicines for patients. Our leaders champion projects with Data Science foundations – such as incorporating emerging datasets and advanced analytics into strategic and operational R&D plans – because we passionately believe that Data Science can create efficiencies and advancements to drive effectiveness in drug discovery and development. Read the featured stories above and explore our key capabilities below to understand where and how Janssen Research & Development enables the use of Data Science to bring transformational medicines to patients faster than ever before.
Partner with Us
We value and nurture external partnerships because we believe the best scientists, investors, and entrepreneurs can come from anywhere. Creating a culture of transparency and collaboration is crucial to maximizing opportunities to develop new medicines and positively impact the healthcare landscape. From a leading biomedical artificial intelligence startup profiling coronavirus receptor, to the development of a predictive model to enhance oncology clinical development programs, to a 15-year United Kingdom government-funded initiative to accumulate genetic and phenotypic data, our partnerships are on the cutting edge of data science and creating real world impact on patients’ lives.